BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 16612777)

  • 1. [Treatment of carcinoma of the pancreatic head].
    Hopt UT
    Zentralbl Chir; 2006 Apr; 131(2):115-20. PubMed ID: 16612777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The multidisciplinary management of gastrointestinal cancer. Pancreatic cancer: from pathogenesis to cure.
    Ducreux M; Boige V; Goéré D; Deutsch E; Ezra P; Elias D; Malka D
    Best Pract Res Clin Gastroenterol; 2007; 21(6):997-1014. PubMed ID: 18070700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Surgical treatment of carcinoma of the pancreas].
    Doi R; Kami K; Ito D; Kawaguchi Y; Uemoto S; Yoshida S
    Nihon Geka Gakkai Zasshi; 2006 Jul; 107(4):168-72. PubMed ID: 16878408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Neoadjuvant and adjuvant therapy of ductal pancreatic carcinoma].
    Hohenberger W; Kastl S
    Zentralbl Chir; 2000; 125(4):348-55. PubMed ID: 10829315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An evidence-based approach to the surgical management of resectable pancreatic adenocarcinoma.
    Stojadinovic A; Brooks A; Hoos A; Jaques DP; Conlon KC; Brennan MF
    J Am Coll Surg; 2003 Jun; 196(6):954-64. PubMed ID: 12788434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of exocrine pancreas tumors].
    Baumel H; Huguier M; Fabre JM; Houry S; Domergue J
    Ann Chir; 1991; 45(3):253-8. PubMed ID: 2042920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pancreatic liver metastases after curative resection combined with intraoperative radiation for pancreatic cancer.
    Takamori H; Hiraoka T; Kanemitsu K; Tsuji T
    Hepatogastroenterology; 2004; 51(59):1500-3. PubMed ID: 15362786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Possibilities and limits of cytostatic chemotherapy in pancreatic carcinoma].
    Scheithauer W
    Wien Klin Wochenschr; 1994; 106(22):704-8. PubMed ID: 7825320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pancreatic carcinoma--the status of extensive interventions].
    Pratschner T; Karner J
    Wien Klin Wochenschr; 1994; 106(22):709-12. PubMed ID: 7825321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pancreatic carcinoma. Optimizing therapy by adjuvant and neoadjuvant therapy?].
    Maurer CA; Zgraggen K; Büchler MW
    Zentralbl Chir; 1999; 124(5):401-7. PubMed ID: 10420525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Surgery for pancreatic cancer].
    Welsch T; Büchler MW; Schmidt J
    Z Gastroenterol; 2008 Dec; 46(12):1393-403. PubMed ID: 19053009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conclusions from the European Study Group for Pancreatic Cancer adjuvant trial of chemoradiotherapy and chemotherapy for pancreatic cancer.
    Ghaneh P; Neoptolemos JP
    Surg Oncol Clin N Am; 2004 Oct; 13(4):567-87, vii-viii. PubMed ID: 15350935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenocarcinoma of the pancreas: the rationale for neoadjuvant therapy.
    Sperti C; Pasquali C; Pastorelli D; Ferronato A; Decet G; Pedrazzoli S
    Acta Biomed; 2003; 74 Suppl 2():91-5. PubMed ID: 15055044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The case for routine use of adjuvant therapy in pancreatic cancer.
    Kennedy EP; Yeo CJ
    J Surg Oncol; 2007 Jun; 95(7):597-603. PubMed ID: 17230543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pancreatic resections after chemoradiotherapy for locally advanced ductal adenocarcinoma: analysis of perioperative outcome and survival.
    Massucco P; Capussotti L; Magnino A; Sperti E; Gatti M; Muratore A; Sgotto E; Gabriele P; Aglietta M
    Ann Surg Oncol; 2006 Sep; 13(9):1201-8. PubMed ID: 16955382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjuvant therapy for pancreatic cancer: an evolving paradigm.
    Zhu AX; Clark JW; Willett CG
    Surg Oncol Clin N Am; 2004 Oct; 13(4):605-20, viii. PubMed ID: 15350937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term survival (5-20 years) after pancreatectomy for pancreatic ductal adenocarcinoma: a series of 30 patients collected from 3 institutions.
    Adham M; Jaeck D; Le Borgne J; Oussoultzouglou E; Chenard-Neu MP; Mosnier JF; Scoazec JY; Mornex F; Partensky C
    Pancreas; 2008 Nov; 37(4):352-7. PubMed ID: 18665012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modern management of pancreatic carcinoma.
    Goldstein D; Carroll S; Apte M; Keogh G
    Intern Med J; 2004 Aug; 34(8):475-81. PubMed ID: 15317546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. D1 versus D2 pancreatoduodenectomy in surgical therapy of pancreatic head cancer.
    Gazzaniga GM; Cappato S; Papadia F; Mori L; Filauro M
    Hepatogastroenterology; 2001; 48(41):1471-8. PubMed ID: 11677990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjuvant therapy for adenocarcinoma of the pancreas: analysis of reported trials and recommendations for future progress.
    Wolff RA; Varadhachary GR; Evans DB
    Ann Surg Oncol; 2008 Oct; 15(10):2773-86. PubMed ID: 18612703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.